查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1751249

放射肿瘤学市场规模、份额、趋势分析报告（按类型、技术、应用、地区、细分市场预测），2025 年至 2030 年

Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

放射肿瘤学市场的成长和趋势：

根据Grand View Research, Inc.的最新报告，全球放射肿瘤学市场规模预计到2030年将达到211.9亿美元，2025年至2030年期间的复合年增长率为11.17%。

市场的成长归因于全球癌症负担的增加、老年人口的成长以及政府和私人机构实施的支持性报销计划。此外，放射治疗技术的不断创新和进步也为市场成长提供了丰厚的利润机会。

在全球范围内，癌症患者的发生率不断上升，这是推动放射肿瘤学市场成长的主要因素。例如，根据Globocan的数据，2020年将有超过2,000万人被诊断出罹患癌症，并将有1,000万人死于癌症。此外，由于免疫力下降和合併症，老龄化社会导致癌症风险更高。因此，老年人口的成长进一步推动了市场的成长。例如，根据世界卫生组织的估计，2020年全球老年人口约为10亿，预计2050年将达到21亿人。

为开发新型放射治疗技术和多学科治疗方法而进行的广泛研究活动有望​​提高癌症患者的存活率并改善预后。例如，2022年12月，Elekta Unity展示了磁振造影直线加速器（MR-Linac）在胰臟肿瘤治疗中的应用，并首次为历史上首位患者采用了新型先进放射治疗运动管理技术。

同样在2020年6月，Isoray与辛辛那提大学医师公司签署了一项协议，以研究颈部和头部癌症的治疗。两家公司将评估Keytruda与铯-131合併用于手术切除后的疗效。此类医用同位素在癌症治疗中的应用可能有助于了解疾病的复杂性和患者的需求，并促进新型特异性放射治疗系统的研究开发。

此外，针对放射治疗的支持性报销和监管政策也有望推动放射肿瘤学市场的成长。例如，2021年7月，美国医疗保险和医疗补助服务中心 (CMS) 针对癌症诊断和放射治疗服务制定了新的放射肿瘤学支付模式 (RO-APM)，这将提高患者护理品质并减少年度医疗保险支出。

放射肿瘤学市场报告重点

  • 由于线性加速器(LINAC)、微型先进收益占有率系统等在治疗各种癌症方面的应用日益广泛，体外放射治疗(EBRT) 市场在 2024 年占据了整个市场中最大的收入份额。
  • 2024 年，IMRT 部门占据了最大的收益占有率，为 24.06%，这归因于治疗需求巨大的以及治疗需求未得到满足的国家中技术先进的强度调控放射治疗(IMRT) 的日益普及。
  • 前列腺癌 EBRT 领域在 2024 年占据最大收益占有率，为 58.65%，预计在预测期内仍将保持主导地位。
  • 由于癌症发生率的上升和新兴市场产品采用率的提高，IBRT 市场预计在预测期内将显着增长。
  • 由于政府的有利倡议和技术先进的放射治疗设备，北美放射肿瘤学产业在 2024 年占据全球收益占有率%。

目录

第一章调查方法与范围

第二章执行摘要

第三章放射肿瘤学市场变数、趋势和范围

  • 市场区隔和范围
  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
    • 增加放射治疗的使用
    • 放射治疗技术的进步
    • 癌症发生率上升
    • 医疗成本上涨
    • 扩大放射性药物的应用
  • 市场限制因素分析
    • 熟练放射治疗师短缺
    • 辐射基础设施不足
    • 放射线治疗副作用类型分析工具
    • 波特五力分析
    • PESTEL分析

第四章放射肿瘤学市场：按类型估计和趋势分析

  • 放射肿瘤学市场：按类型变化分析
  • 按类型
  • 体外放射线治疗
    • 线性加速器（linac）
    • 紧凑型先进放射治疗系统
    • 质子治疗
  • 内部放射治疗
    • 放射线治疗
    • 全身放射线治疗
    • 其他的

第五章放射肿瘤学市场：按技术分類的估计和趋势分析

  • 放射肿瘤学市场：依技术分類的差异分析
  • 依技术
  • 体外放射线治疗
    • 影像导航放射治疗(IGRT)
    • 强度调控放射治疗(IMRT)
    • 立体定位放射治疗技术
    • 质子治疗
    • 3D适形放射治疗（3D CRT）
    • 容积调强弧形治疗 (VMAT)
  • 放射线治疗
    • 低剂量近距离放射治疗
    • 高剂量近距离放射治疗

第六章放射肿瘤学市场：按应用的估计和趋势分析

  • 放射肿瘤学市场：按应用进行的变化分析
  • 按用途
  • 体外放射线治疗
    • 摄护腺癌
    • 乳癌
    • 肺癌
    • 头颈癌
    • 大肠直肠癌
    • 其他的
  • 内部放射治疗
    • 摄护腺癌
    • 乳癌
    • 肺癌
    • 头颈癌
    • 大肠直肠癌
    • 其他的

第七章放射肿瘤学市场：区域估计和趋势分析

  • 2024 年及 2030 年各地区放射肿瘤学市场占有率
  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场概况
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 2018-2030年北美放射肿瘤学市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲放射肿瘤学市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区放射肿瘤学市场
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030年拉丁美洲放射肿瘤学市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年中东及非洲放射肿瘤学市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 战略地图
  • 2024年公司市场占有率分析
  • 公司简介
    • Varian Medical Systems, Inc.
    • Elekta AB
    • Accuray Incorporated
    • IBA Radiopharma Solutions
    • BD（Becton, Dickinson and Company）
    • Isoray Inc.
    • Mevion Medical Systems
    • Nordion, Inc.
    • NTP Radioisotopes SOC Ltd.
    • Curium
    • ViewRay Technologies, Inc.
Product Code: GVR-1-68038-801-5

Radiation Oncology Market Growth & Trends:

The global radiation oncology market size is expected to reach USD 21.19 billion in 2030 and is projected to grow at a CAGR of 11.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the global rise in cancer burden, the growing geriatric population, and supportive reimbursement programs undertaken by the government and private organizations. Furthermore, the increasing technological innovation and advancement in radiotherapy offer lucrative opportunities for market growth.

The world is witnessing an increasing prevalence of cancer cases which is the key factor driving the radiation oncology market growth. For instance, according to Globocan, in 2020, more than 20.0 million people were diagnosed with cancer, and 10.0 million died of cancer. Moreover, the aging population is at high risk of cancer due to a weak immune system and comorbid conditions; thereby, the rising geriatric population further fuels market growth. For instance, in 2020, according to WHO estimates, the global geriatric population was approximately 1.0 billion and is expected to reach 2.1 billion by 2050.

Extensive research activities for the development of novel radiotherapy techniques and multidisciplinary therapeutic approaches are expected to lead to an increased survival rate and a more favorable prognosis of cancer. For instance, in December 2022, Elekta Unity demonstrated MR-Linac use for pancreatic tumors, where the first-ever patient was treated with new advanced radiotherapy motion management.

Similarly, in June 2020, Isoray signed a research agreement with the University of Cincinnati Physicians Company to study neck and head cancer treatment. The companies will evaluate the efficacy of Keytruda along with Cesium-131 post-surgical resection. Using such medical isotopes for cancer treatment may boost the research in developing a new target-specific radiation therapy system by understanding disease complexity & patients' need, thereby widening the opportunity in the market.

Furthermore, supportive reimbursement and regulatory policies for radiation therapy are also expected to drive the radiation oncology market growth. For instance, in July 2021, the Centers for Medicare and Medicaid Services (CMS) developed a new Radiation Oncology Payment Model (RO-APM) for the diagnosis of cancer and radiotherapy services. It enhances the quality of care of the patients and reduces the annual Medicare expenditure.

Radiation Oncology Market Report Highlights:

  • The external beam radiation therapy (EBRT) market, which includes linear accelerators (Linac), and compact advanced radiotherapy systems, dominated the overall market with the largest revenue share in 2024 due to increased adoption in the treatment of various types of cancers
  • The IMRT segment held the largest revenue share of 24.06% in 2024, attributed to the substantial demand for treatment and increased availability of technologically advanced intensity-modulated radiotherapy (IMRT) in countries with unmet treatment needs.
  • The EBRT segment for prostate cancer held the largest revenue share of 58.65% in 2024 and is anticipated to maintain its dominance over the forecast period
  • The market for IBRT is anticipated to witness significant growth over the forecast period due to the growing prevalence of cancer in developing countries and increased product penetration
  • North America radiation oncology industry dominated globally in terms of revenue share of 47.16% in 2024, owing to the favorable government initiatives and availability of technologically advanced radiotherapy equipment

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Technology
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Applicationoutlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Radiation Oncology Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising adoption of radiotherapy
    • 3.4.2. Technological advancements in radiotherapy
    • 3.4.3. Rising prevalence of cancer
    • 3.4.4. Increase in healthcare expenditure
    • 3.4.5. Increasing application of radiopharmaceuticalsg
  • 3.5. Market Restraint Analysis
    • 3.5.1. Lack Of Skilled Radiotherapy Professionals
    • 3.5.2. Inadequate Radiation Infrastructure
    • 3.5.3. Adverse Effects Of RadiotherapyType Analysis Tools
    • 3.5.4. Porter's Five Forces Analysis
    • 3.5.5. PESTEL Analysis

Chapter 4. Radiation Oncology Market: Type Estimates & Trend Analysis

  • 4.1. Radiation Oncology Market: Type Movement Analysis
  • 4.2. Radiation Oncology Market Estimates and Forecast, by Type
  • 4.3. External Beam Radiation Therapy
    • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2. Linear Accelerators (Linac)
      • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.3. Compact advanced radiotherapy systems
      • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.2. Cyberknife
        • 4.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.3. Gamma Knife
        • 4.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.4. Tomotherapy
        • 4.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.4. Proton Therapy
      • 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.4.2. Cyclotron
        • 4.3.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.4.3. Synchrotron
        • 4.3.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4. Internal Beam Radiation Therapy
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Brachytherapy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Seeds
        • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Applicators and After loaders
        • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Electronic Brachytherapy
        • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Systemic Beam Radiation Therapy
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Radiation Oncology Market: Technology Estimates & Trend Analysis

  • 5.1. Radiation Oncology Market: Technology Movement Analysis
  • 5.2. Radiation Oncology Market Estimates and Forecast, by Technology
  • 5.3. External Beam Radiation Therapy
    • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Image-Guided Radiotherapy (IGRT)
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Intensity Modulated Radiotherapy (IMRT)
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Stereotactic Technology
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Proton Beam Therapy
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.6. 3D Conformal Radiotherapy (3D CRT)
    • 5.3.7. Volumetric Modulated Arc Therapy (VMAT)
      • 5.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Brachytherapy
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Low-Dose Rate Brachytherapy
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. High-Dose Rate Brachytherapy
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Radiation Oncology Market: Application Estimates & Trend Analysis

  • 6.1. Radiation Oncology Market: Application Movement Analysis
  • 6.2. Radiation Oncology Market Estimates and Forecast, by End Use
  • 6.3. External Beam Radiation Therapy
    • 6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Prostate Cancer
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Breast Cancer
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Lung Cancer
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.5. Head and Neck Cancer
      • 6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.6. Colorectal Cancer
      • 6.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.7. Others
      • 6.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Internal Beam Radiation Therapy
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Prostate Cancer
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Breast Cancer
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Lung Cancer
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Head and Neck Cancer
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Colorectal Cancer
      • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Others
      • 6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Radiation Oncology Market: Regional Estimates & Trend Analysis

  • 7.1. Radiation Oncology Market Share By Region, 2024 & 2030
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Global Regional Market Snapshot
  • 7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. North America Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. U.S. Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.3. Canada
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Canada Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.4. Mexico
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Mexico Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.7. Europe
    • 7.7.1. Europe Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.2. UK
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. UK Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.3. Germany
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Germany Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.4. France
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. France Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.5. Italy
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Italy Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.6. Spain
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Spain Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.7. Denmark
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Denmark Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.8. Sweden
      • 7.7.8.1. Key Country Dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory Framework
      • 7.7.8.4. Sweden Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.9. Norway
      • 7.7.9.1. Key Country Dynamics
      • 7.7.9.2. Competitive Scenario
      • 7.7.9.3. Regulatory Framework
      • 7.7.9.4. Norway Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.8. Asia Pacific
    • 7.8.1. Asia Pacific Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.2. Japan
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Japan Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.3. China
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. China Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.4. India
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. India Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.5. Australia
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Australia Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.6. Thailand
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Thailand Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.7. South Korea
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Competitive Scenario
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. South Korea Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.9. Latin America
    • 7.9.1. Latin America Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.9.2. Brazil
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Brazil Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.9.3. Argentina
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Argentina Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.10. MEA
    • 7.10.1. MEA Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.2. South Africa
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Competitive Scenario
      • 7.10.2.3. Regulatory Framework
      • 7.10.2.4. South Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.3. Saudi Arabia
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Competitive Scenario
      • 7.10.3.3. Regulatory Framework
      • 7.10.3.4. Saudi Arabia Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.4. UAE
      • 7.10.4.1. Key Country Dynamics
      • 7.10.4.2. Competitive Scenario
      • 7.10.4.3. Regulatory Framework
      • 7.10.4.4. UAE Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.5. Kuwait
      • 7.10.5.1. Key Country Dynamics
      • 7.10.5.2. Competitive Scenario
      • 7.10.5.3. Regulatory Framework
      • 7.10.5.4. Kuwait Radiation Oncology Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Strategy Mapping
  • 8.4. Company Market Share Analysis, 2024
  • 8.5. Company Profiles
    • 8.5.1. Varian Medical Systems, Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Elekta AB
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Accuray Incorporated
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. IBA Radiopharma Solutions
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. BD (Becton, Dickinson and Company)
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Isoray Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Mevion Medical Systems
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Nordion, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. NTP Radioisotopes SOC Ltd.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Curium
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. ViewRay Technologies, Inc.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 3 Global Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 Global Radiation Oncology Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 9 North America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Europe America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Europe America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 UK Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 UK Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 UK Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 Germany Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 France Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 France Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 France Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Italy Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Italy Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32 Spain Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Spain Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Spain Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Sweden Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Norway Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Norway Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Norway Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Japan Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Japan Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Japan Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 China Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 China Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 China Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 55 India Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 India Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 India Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Australia Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Australia Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 Australia Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Thailand Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Thailand Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 Thailand Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 South Korea Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 Latin America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Brazil Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Mexico Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Radiation Oncology Market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 audi Arabia Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 90 UAE Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Radiation Oncology Market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Radiation oncology market: Type movement analysis
  • Fig. 15 Radiation oncology market: Type outlook and key takeaways
  • Fig. 16 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 17 Linear Accelerators (Linac) market estimates and forecast, 2018 - 2030
  • Fig. 18 Compact advanced radiotherapy systems market estimates and forecast, 2018 - 2030
  • Fig. 19 Cyberknife market estimates and forecast, 2018 - 2030
  • Fig. 20 Gamma Knife market estimates and forecast, 2018 - 2030
  • Fig. 21 Tomotherapy market estimates and forecast, 2018 - 2030
  • Fig. 22 Proton Therapy market estimates and forecast, 2018 - 2030
  • Fig. 23 Cyclotron market estimates and forecast, 2018 - 2030
  • Fig. 24 Synchrotron market estimates and forecast, 2018 - 2030
  • Fig. 25 Internal Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 26 Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 27 Seeds market estimates and forecast, 2018 - 2030
  • Fig. 28 Applicators and After loaders market estimates and forecast, 2018 - 2030
  • Fig. 29 Electronic Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 30 Systemic Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Radiation oncology market: Technology movement analysis
  • Fig. 33 Radiation oncology market: Technology outlook and key takeaways
  • Fig. 34 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 35 Image-Guided Radiotherapy (IGRT) market estimates and forecast, 2018 - 2030
  • Fig. 36 Intensity Modulated Radiotherapy (IMRT) market estimates and forecast, 2018 - 2030
  • Fig. 37 Stereotactic Technology market estimates and forecast, 2018 - 2030
  • Fig. 38 Proton Beam Therapy market estimates and forecast, 2018 - 2030
  • Fig. 39 3D Conformal Radiotherapy (3D CRT) market estimates and forecast, 2018 - 2030
  • Fig. 40 Volumetric Modulated Arc Therapy (VMAT) market estimates and forecast, 2018 - 2030
  • Fig. 41 Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 42 Low-Dose Rate Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 43 High-Dose Rate Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 44 Radiation oncology market: Application movement analysis
  • Fig. 45 Radiation oncology market: Application outlook and key takeaways
  • Fig. 46 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 47 Prostate Cancer market estimates and forecast, 2018 - 2030
  • Fig. 48 Breast Cancer market estimates and forecast, 2018 - 2030
  • Fig. 49 Lung Cancer market estimates and forecast, 2018 - 2030
  • Fig. 50 Head and Neck Cancer market estimates and forecast, 2018 - 2030
  • Fig. 51 Colorectal Cancer market estimates and forecast, 2018 - 2030
  • Fig. 52 Others market estimates and forecast, 2018 - 2030
  • Fig. 53 Internal Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 54 Prostate Cancer market estimates and forecast, 2018 - 2030
  • Fig. 55 Gynecological Cancer market estimates and forecast, 2018 - 2030
  • Fig. 56 Cervical Cancer market estimates and forecast, 2018 - 2030
  • Fig. 57 Breast Cancer market estimates and forecast, 2018 - 2030
  • Fig. 58 Penile Cancer market estimates and forecast, 2018 - 2030
  • Fig. 59 Others market estimates and forecast, 2018 - 2030
  • Fig. 60 Regional outlook, 2024 & 2030
  • Fig. 61 Global Radiation Oncology Market: Region movement analysis
  • Fig. 62 North America Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 63 U.S. Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 64 Canada Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 66 Europe Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 67 Germany Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 68 UK Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 69 France Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 70 Italy Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 72 Denmark Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 73 Sweden Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 74 Norway Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 77 China Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 78 India Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 81 Thailand Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 84 Argentina Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 85 Middle East and Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 87 Saudi Arabia Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 88 UAE Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait Radiation Oncology Market, 2018 - 2030 (USD Million)